Sign In

Login

Password

Forgot Password ? Sign Up

Bronowski Institute of Behavioural Neuroscience (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Bronowski Institute of Behavioural Neuroscience" in English language version.

refsWebsite
Global rank English rank
8nih.gov
4th place
4th place
7doi.org
2nd place
2nd place
2harvard.edu
18th place
17th place
1degruyter.com
1,425th place
1,138th place
1jstor.org
26th place
20th place

degruyter.com (Global: 1,425th place; English: 1,138th place)

doi.org (Global: 2nd place; English: 2nd place)

  • Willis, G. L.; Moore, C.; Armstrong, S. M. (2014). "Parkinson's disease, lights and melanocytes: looking beyond the retina". Scientific Reports. 4 (3921): 3921. Bibcode:2014NatSR...4E3921W. doi:10.1038/srep03921. PMC 5379242. PMID 24473093.
  • Willis, G. L.; Armstrong, S. M. (1999). "A therapeutic role for melatonin antagonism in experimental models of Parkinson's disease"". Physiology & Behavior. 66 (5): 785–795. doi:10.1016/s0031-9384(99)00023-2. PMID 10405106.
  • Willis, G. L.; Moore, C.; Armstrong, S. M. (2012). "A historical justification for and retrospective analysis of the systematic application of light therapy in Parkinson's disease". Reviews in the Neurosciences. 23 (2): 199–226. doi:10.1515/revneuro-2011-0072. PMID 22499678.
  • Willis, G. L.; Moore, C.; Armstrong, S. M. (2012). "Breaking away from dopamine deficiency: an essential new direction for Parkinson's disease". Reviews in the Neurosciences. 23 (4): 403–428. doi:10.1515/revneuro-2012-0037. PMID 23089606.
  • Cohen, J. (1998). "Scientists who fund themselves". Science. 279 (5348): 178–181. Bibcode:1998Sci...279..178C. doi:10.1126/science.279.5348.178. JSTOR 2893977. PMID 9446224.
  • Willis, G. L. (2008). "Parkinson's disease as a neuroendocrine disorder of circadian function: dopamine-melatonin imbalance and the visual system in the genesis and progression of the degenerative process". Reviews in the Neurosciences. 19 (4–5): 245–316. doi:10.1515/REVNEURO.2008.19.4-5.245. PMID 19145986.
  • Willis, G. L.; Turner, E. J. D. (2007). "Primary and secondary features of Parkinson's disease improve with strategic exposure to bright light: a case series study". Chronobiology International. 24 (3): 521–537. doi:10.1080/07420520701420717. PMID 17612949.

harvard.edu (Global: 18th place; English: 17th place)

ui.adsabs.harvard.edu

  • Willis, G. L.; Moore, C.; Armstrong, S. M. (2014). "Parkinson's disease, lights and melanocytes: looking beyond the retina". Scientific Reports. 4 (3921): 3921. Bibcode:2014NatSR...4E3921W. doi:10.1038/srep03921. PMC 5379242. PMID 24473093.
  • Cohen, J. (1998). "Scientists who fund themselves". Science. 279 (5348): 178–181. Bibcode:1998Sci...279..178C. doi:10.1126/science.279.5348.178. JSTOR 2893977. PMID 9446224.

jstor.org (Global: 26th place; English: 20th place)

nih.gov (Global: 4th place; English: 4th place)

pubmed.ncbi.nlm.nih.gov

  • Willis, G. L.; Moore, C.; Armstrong, S. M. (2014). "Parkinson's disease, lights and melanocytes: looking beyond the retina". Scientific Reports. 4 (3921): 3921. Bibcode:2014NatSR...4E3921W. doi:10.1038/srep03921. PMC 5379242. PMID 24473093.
  • Willis, G. L.; Armstrong, S. M. (1999). "A therapeutic role for melatonin antagonism in experimental models of Parkinson's disease"". Physiology & Behavior. 66 (5): 785–795. doi:10.1016/s0031-9384(99)00023-2. PMID 10405106.
  • Willis, G. L.; Moore, C.; Armstrong, S. M. (2012). "A historical justification for and retrospective analysis of the systematic application of light therapy in Parkinson's disease". Reviews in the Neurosciences. 23 (2): 199–226. doi:10.1515/revneuro-2011-0072. PMID 22499678.
  • Willis, G. L.; Moore, C.; Armstrong, S. M. (2012). "Breaking away from dopamine deficiency: an essential new direction for Parkinson's disease". Reviews in the Neurosciences. 23 (4): 403–428. doi:10.1515/revneuro-2012-0037. PMID 23089606.
  • Cohen, J. (1998). "Scientists who fund themselves". Science. 279 (5348): 178–181. Bibcode:1998Sci...279..178C. doi:10.1126/science.279.5348.178. JSTOR 2893977. PMID 9446224.
  • Willis, G. L. (2008). "Parkinson's disease as a neuroendocrine disorder of circadian function: dopamine-melatonin imbalance and the visual system in the genesis and progression of the degenerative process". Reviews in the Neurosciences. 19 (4–5): 245–316. doi:10.1515/REVNEURO.2008.19.4-5.245. PMID 19145986.
  • Willis, G. L.; Turner, E. J. D. (2007). "Primary and secondary features of Parkinson's disease improve with strategic exposure to bright light: a case series study". Chronobiology International. 24 (3): 521–537. doi:10.1080/07420520701420717. PMID 17612949.

ncbi.nlm.nih.gov

  • Willis, G. L.; Moore, C.; Armstrong, S. M. (2014). "Parkinson's disease, lights and melanocytes: looking beyond the retina". Scientific Reports. 4 (3921): 3921. Bibcode:2014NatSR...4E3921W. doi:10.1038/srep03921. PMC 5379242. PMID 24473093.